Pre-emptive pharmacogenetic (PGx) testing using a multiple gene panel to guide treatment and reduce adverse drug reactions

Topic Status Complete

Pre-emptive pharmacogenetic (PGx) testing using a multiple gene panel to guide treatment decisions

Summary

 

Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of pre-emptive testing using a PGx panel to guide treatment and reduce adverse drug reactions.

 

The HTW Assessment Group decided not to progress this topic further due to the lack of evidence of effectiveness at present.

Topic Exploration Report

TER465 09.2023